Arylamine N‐acetyltransferases: from drug metabolism and pharmacogenetics to drug discovery

E Sim, A Abuhammad, A Ryan - British Journal of …, 2014 - Wiley Online Library
Arylamine N‐acetyltransferases (NAT s) are polymorphic drug‐metabolizing enzymes,
acetylating arylamine carcinogens and drugs including hydralazine and sulphonamides …

New approaches to target the mycolic acid biosynthesis pathway for the development of tuberculosis therapeutics

E Jeffrey North, M Jackson… - Current pharmaceutical …, 2014 - ingentaconnect.com
Mycolic acids are the major lipid components of the unique mycobacterial cell wall
responsible for the protection of the tuberculosis bacilli from many outside threats. Mycolic …

Cholesterol utilization in mycobacteria is controlled by two TetR-type transcriptional regulators: kstR and kstR2

SL Kendall, P Burgess, R Balhana… - …, 2010 - microbiologyresearch.org
Mycobacterium tuberculosis is able to use a variety of carbon sources in vivo and current
knowledge suggests that cholesterol is used as a carbon source during infection. The …

Characterisation of ATP-Dependent Mur Ligases Involved in the Biogenesis of Cell Wall Peptidoglycan in Mycobacterium tuberculosis

T Munshi, A Gupta, D Evangelopoulos, JD Guzman… - PloS one, 2013 - journals.plos.org
ATP-dependent Mur ligases (Mur synthetases) play essential roles in the biosynthesis of cell
wall peptidoglycan (PG) as they catalyze the ligation of key amino acid residues to the stem …

Characterization of a carbon-carbon hydrolase from Mycobacterium tuberculosis involved in cholesterol metabolism

NA Lack, KC Yam, ED Lowe, GP Horsman… - Journal of Biological …, 2010 - ASBMB
In the recently identified cholesterol catabolic pathway of Mycobacterium tuberculosis, 2-
hydroxy-6-oxo-6-phenylhexa-2, 4-dienoate hydrolase (HsaD) is proposed to catalyze the …

Arylamine N-acetyltransferases–from drug metabolism and pharmacogenetics to identification of novel targets for pharmacological intervention

E Sim, G Fakis, N Laurieri, S Boukouvala - Advances in pharmacology, 2012 - Elsevier
Arylamine N-acetyltransferases (NATs) are defined as xenobiotic metabolizing enzymes,
adding an acetyl group from acetyl coenzyme A (CoA) to arylamines and arylhydrazines …

Identification of arylamine N-acetyltransferase inhibitors as an approach towards novel anti-tuberculars

IM Westwood, S Bhakta, AJ Russell, E Fullam… - Protein & …, 2010 - academic.oup.com
New anti-tubercular drugs and drug targets are urgently needed to reduce the time for
treatment and also to identify agents that will be effective against Mycobacterium …

Insights into the genomic and functional divergence of NAT gene family to serve microbial secondary metabolism

S Boukouvala, E Kontomina, I Olbasalis… - Scientific Reports, 2024 - nature.com
Microbial NAT enzymes, which employ acyl-CoA to acylate aromatic amines and
hydrazines, have been well-studied for their role in xenobiotic metabolism. Some …

Direct capture, inhibition and crystal structure of HsaD (Rv3569c) from M. tuberculosis

S Barelier, R Avellan, GR Gnawali… - The FEBS …, 2023 - Wiley Online Library
A hallmark of Mycobacterium tuberculosis (M. tb), the aetiologic agent of tuberculosis, is its
ability to metabolise host‐derived lipids. However, the enzymes and mechanisms underlying …

Structure of arylamine N-acetyltransferase from Mycobacterium tuberculosis determined by cross-seeding with the homologous protein from M. marinum: triumph over …

A Abuhammad, ED Lowe, MA McDonough… - … Section D: Biological …, 2013 - scripts.iucr.org
Arylamine N-acetyltransferase from Mycobacterium tuberculosis (TBNAT) plays an important
role in the intracellular survival of the microorganism inside macrophages. Medicinal …